4//SEC Filing
Booth Andrew 4
Accession 0001209191-22-062412
CIK 0001703057other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 2:31 PM ET
Size
9.5 KB
Accession
0001209191-22-062412
Insider Transaction Report
Form 4
Booth Andrew
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Shares
2022-12-20$0.19/sh+50,000$9,500→ 188,500 total - Gift
Common shares
2022-12-20−50,000→ 138,500 total - Exercise/Conversion
Share option (right to buy)
2022-12-20−50,000→ 5,820,481 totalExercise: $0.19Exp: 2026-06-15→ Common shares (50,000 underlying)
Holdings
- 130,959(indirect: By Spouse)
Common shares
Footnotes (2)
- [F1]This transaction represents a charitable donation of 50,000 common shares the reporting person donated on December 20, 2022.
- [F2]The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001834411
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 2:31 PM ET
- Size
- 9.5 KB